APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Cyazofamid

Cyazofamid is a kind of sulfamethoxazole fungicides with light yellow solid powder, which has high biological activity against the fungi.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Cyazofamid is a kind of sulfamethoxazole fungicides with light yellow solid powder, which has high biological activity against the fungi.

Cyazofamid, discovered and developed by ISHIHARA SANGYO KAISHA on the global basis after first launched in 2001, is often used in downy mildew, oomycetes diseases, pepper and others.

Cyazofamid has good toxicological, environmental and ecotoxicological profiles.

In this report, we count technical grade and chapter 6 displays the preparation content.

Selected research

Market Analysis & Forecast

Global Cyazofamid Market Analysis and Forecast 2026-2032

Report ID 17301578022 January 2026190 pages

Choose your research edition.

Industry ResearchCyazofamid Industry Research Report 2026106 pages · $2,950 USDIndustry Growth & TrendsGlobal Cyazofamid Industry Growth and Trends Forecast to 203274 pages · $3,450 USDMarket StructureGlobal Cyazofamid Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032170 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Cyazofamid Market Outlook and Growth Opportunities 2026192 pages · $4,250 USDMarket Analysis & ForecastGlobal Cyazofamid Market Analysis and Forecast 2026-2032190 pages · $4,950 USD

Market perspective

Cyazofamid is a kind of sulfamethoxazole fungicides with light yellow solid powder, which has high biological activity against the fungi.

Cyazofamid, discovered and developed by ISHIHARA SANGYO KAISHA on the global basis after first launched in 2001, is often used in downy mildew, oomycetes diseases, pepper and others.

Cyazofamid has good toxicological, environmental and ecotoxicological profiles.

Read the full market overview

In this report, we count technical grade and chapter 6 displays the preparation content.

ISHIHARA SANGYO KAISHA is the largest manufacturer in the global market, with the share of 81%.

The consumption shares of Japan, China, North America and Europe were 42%, 21%, 17% and 11%. Japan is the main import region and other countries need to import from Japan.

This report presents an overview of global market for Cyazofamid, capacity, output, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Cyazofamid, also provides the consumption of main regions and countries. Of the upcoming market potential for Cyazofamid, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Cyazofamid sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Cyazofamid market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Cyazofamid sales, projected growth trends, production technology, application and end-user industry.

Cyazofamid Segment by Company

ISHIHARA SANGYO KAISHA

Rudong Zhongyi

Cyazofamid Segment by Type

Agriculture Grade

Others

Cyazofamid Segment by Application

Downy Mildew

Oomycetes Diseases

Others

Cyazofamid Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Cyazofamid market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Cyazofamid and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Cyazofamid.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Cyazofamid production/output of global and key producers (regions/countries). It provides a quantitative analysis of the production, and development potential of each producer in the next six years.

Chapter 4: Sales (consumption), revenue of Cyazofamid in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 5: Detailed analysis of Cyazofamid manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 6: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 7: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 8: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Cyazofamid sales, revenue, price, gross margin, and recent development, etc.

Chapter 9: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 10: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 11: China by type, by application, sales, and revenue for each segment.

Chapter 12: Asia (Excluding China) by type, by application and by region, sales, and revenue for each segment.

Chapter 13: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 14: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 15: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Cyazofamid Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Agriculture Grade Major Manufacturers Table 3. Others Major Manufacturers Table 4. Global Cyazofamid Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Downy Mildew Major Manufacturers Table 6. Oomycetes Diseases Major Manufacturers Table 7. Others Major Manufacturers Table 8. Cyazofamid Industry Trends Table 9. Cyazofamid Industry Drivers Table 10. Cyazofamid Industry Opportunities and Challenges Table 11. Cyazofamid Industry Restraints Table 12. Global Cyazofamid Production Growth Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (kt) Table 13. Global Cyazofamid Production by Region (2021-2026) & (kt) Table 14. Global Cyazofamid Production by Region (2027-2032) & (kt) Table 15. Global Cyazofamid Production Market Share by Region (2021-2026) Table 16. Global Cyazofamid Production Market Share by Region (2027-2032) Table 17. Global Cyazofamid Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 18. Global Cyazofamid Revenue by Region (2021-2026) & (US$ Million) Table 19. Global Cyazofamid Revenue by Region (2027-2032) & (US$ Million) Table 20. Global Cyazofamid Revenue Market Share by Region (2021-2026) Table 21. Global Cyazofamid Revenue Market Share by Region (2027-2032) Table 22. Global Cyazofamid Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (kt) Table 23. Global Cyazofamid Sales by Region (2021-2026) & (kt) Table 24. Global Cyazofamid Sales by Region (2027-2032) & (kt) Table 25. Global Cyazofamid Sales Market Share by Region (2021-2026) Table 26. Global Cyazofamid Sales Market Share by Region (2027-2032) Table 27. Global Cyazofamid Revenue by Manufacturers (US$ Million) & (2021-2026) Table 28. Global Cyazofamid Revenue Market Share by Manufacturers (2021-2026) Table 29. Global Cyazofamid Sales by Manufacturers (US$ Million) & (2021-2026) Table 30. Global Cyazofamid Sales Market Share by Manufacturers (2021-2026) Table 31. Global Cyazofamid Sales Price (USD/t) of Manufacturers (2021-2026) Table 32. Global Cyazofamid Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 33. Global Cyazofamid Key Manufacturers Manufacturing Sites & Headquarters Table 34. Global Cyazofamid Manufacturers, Product Type & Application Table 35. Global Cyazofamid Manufacturers Commercialization Time Table 36. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 37. Global Cyazofamid by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 38. Global Cyazofamid Revenue by Type (2021-2026) & (US$ Million) Table 39. Global Cyazofamid Revenue by Type (2027-2032) & (US$ Million) Table 40. Global Cyazofamid Revenue Market Share by Type (2021-2026) Table 41. Global Cyazofamid Revenue Market Share by Type (2027-2032) Table 42. Global Cyazofamid Sales by Type (2021-2026) & (kt) Table 43. Global Cyazofamid Sales by Type (2027-2032) & (kt) Table 44. Global Cyazofamid Sales Market Share by Type (2021-2026) Table 45. Global Cyazofamid Sales Market Share by Type (2027-2032) Table 46. Global Cyazofamid Price by Type (2021-2026) & (USD/t) Table 47. Global Cyazofamid Price by Type (2027-2032) & (USD/t) Table 48. Global Cyazofamid Revenue by Application (2021-2026) & (US$ Million) Table 49. Global Cyazofamid Revenue by Application (2027-2032) & (US$ Million) Table 50. Global Cyazofamid Revenue Market Share by Application (2021-2026) Table 51. Global Cyazofamid Revenue Market Share by Application (2027-2032) Table 52. Global Cyazofamid Sales by Application (2021-2026) & (kt) Table 53. Global Cyazofamid Sales by Application (2027-2032) & (kt) Table 54. Global Cyazofamid Sales Market Share by Application (2021-2026) Table 55. Global Cyazofamid Sales Market Share by Application (2027-2032) Table 56. Global Cyazofamid Price by Application (2021-2026) & (USD/t) Table 57. Global Cyazofamid Price by Application (2027-2032) & (USD/t) Table 58. ISHIHARA SANGYO KAISHA Company Information Table 59. ISHIHARA SANGYO KAISHA Business Overview Table 60. ISHIHARA SANGYO KAISHA Cyazofamid Sales (kt), Revenue (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 61. ISHIHARA SANGYO KAISHA Cyazofamid Product Portfolio Table 62. ISHIHARA SANGYO KAISHA Recent Development Table 63. Rudong Zhongyi Company Information Table 64. Rudong Zhongyi Business Overview Table 65. Rudong Zhongyi Cyazofamid Sales (kt), Revenue (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 66. Rudong Zhongyi Cyazofamid Product Portfolio Table 67. Rudong Zhongyi Recent Development Table 68. North America Cyazofamid Revenue by Type (2021-2026) & (US$ Million) Table 69. North America Cyazofamid Revenue by Type (2027-2032) & (US$ Million) Table 70. North America Cyazofamid Sales by Type (2021-2026) & (kt) Table 71. North America Cyazofamid Sales by Type (2027-2032) & (kt) Table 72. North America Cyazofamid Sales Price by Type (2021-2026) & (USD/t) Table 73. North America Cyazofamid Sales Price by Type (2027-2032) & (USD/t) Table 74. North America Cyazofamid Revenue by Application (2021-2026) & (US$ Million) Table 75. North America Cyazofamid Revenue by Application (2027-2032) & (US$ Million) Table 76. North America Cyazofamid Sales by Application (2021-2026) & (kt) Table 77. North America Cyazofamid Sales by Application (2027-2032) & (kt) Table 78. North America Cyazofamid Sales Price by Application (2021-2026) & (USD/t) Table 79. North America Cyazofamid Sales Price by Application (2027-2032) & (USD/t) Table 80. North America Cyazofamid Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 81. North America Cyazofamid Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 82. North America Cyazofamid Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 83. North America Cyazofamid Sales by Country (2021 VS 2025 VS 2032) & (kt) Table 84. North America Cyazofamid Sales by Country (2021-2026) & (kt) Table 85. North America Cyazofamid Sales by Country (2027-2032) & (kt) Table 86. North America Cyazofamid Sales Price by Country (2021-2026) & (USD/t) Table 87. North America Cyazofamid Sales Price by Country (2027-2032) & (USD/t) Table 88. United States Cyazofamid Revenue (2021-2032) & (US$ Million) Table 89. Canada Cyazofamid Revenue (2021-2032) & (US$ Million) Table 90. Mexico Cyazofamid Revenue (2021-2032) & (US$ Million) Table 91. Europe Cyazofamid Revenue by Type (2021-2026) & (US$ Million) Table 92. Europe Cyazofamid Revenue by Type (2027-2032) & (US$ Million) Table 93. Europe Cyazofamid Sales by Type (2021-2026) & (kt) Table 94. Europe Cyazofamid Sales by Type (2027-2032) & (kt) Table 95. Europe Cyazofamid Sales Price by Type (2021-2026) & (USD/t) Table 96. Europe Cyazofamid Sales Price by Type (2027-2032) & (USD/t) Table 97. Europe Cyazofamid Revenue by Application (2021-2026) & (US$ Million) Table 98. Europe Cyazofamid Revenue by Application (2027-2032) & (US$ Million) Table 99. Europe Cyazofamid Sales by Application (2021-2026) & (kt) Table 100. Europe Cyazofamid Sales by Application (2027-2032) & (kt) Table 101. Europe Cyazofamid Sales Price by Application (2021-2026) & (USD/t) Table 102. Europe Cyazofamid Sales Price by Application (2027-2032) & (USD/t) Table 103. Europe Cyazofamid Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 104. Europe Cyazofamid Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 105. Europe Cyazofamid Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 106. Europe Cyazofamid Sales by Country (2021 VS 2025 VS 2032) & (kt) Table 107. Europe Cyazofamid Sales by Country (2021-2026) & (kt) Table 108. Europe Cyazofamid Sales by Country (2027-2032) & (kt) Table 109. Europe Cyazofamid Sales Price by Country (2021-2026) & (USD/t) Table 110. Europe Cyazofamid Sales Price by Country (2027-2032) & (USD/t) Table 111. Germany Cyazofamid Revenue (2021-2032) & (US$ Million) Table 112. France Cyazofamid Revenue (2021-2032) & (US$ Million) Table 113. U.K. Cyazofamid Revenue (2021-2032) & (US$ Million) Table 114. Italy Cyazofamid Revenue (2021-2032) & (US$ Million) Table 115. Russia Cyazofamid Revenue (2021-2032) & (US$ Million) Table 116. Spain Cyazofamid Revenue (2021-2032) & (US$ Million) Table 117. Netherlands Cyazofamid Revenue (2021-2032) & (US$ Million) Table 118. Switzerland Cyazofamid Revenue (2021-2032) & (US$ Million) Table 119. Sweden Cyazofamid Revenue (2021-2032) & (US$ Million) Table 120. Poland Cyazofamid Revenue (2021-2032) & (US$ Million) Table 121. China Cyazofamid Revenue by Type (2021-2026) & (US$ Million) Table 122. China Cyazofamid Revenue by Type (2027-2032) & (US$ Million) Table 123. China Cyazofamid Sales by Type (2021-2026) & (kt) Table 124. China Cyazofamid Sales by Type (2027-2032) & (kt) Table 125. China Cyazofamid Sales Price by Type (2021-2026) & (USD/t) Table 126. China Cyazofamid Sales Price by Type (2027-2032) & (USD/t) Table 127. China Cyazofamid Revenue by Application (2021-2026) & (US$ Million) Table 128. China Cyazofamid Revenue by Application (2027-2032) & (US$ Million) Table 129. China Cyazofamid Sales by Application (2021-2026) & (kt) Table 130. China Cyazofamid Sales by Application (2027-2032) & (kt) Table 131. China Cyazofamid Sales Price by Application (2021-2026) & (USD/t) Table 132. China Cyazofamid Sales Price by Application (2027-2032) & (USD/t) Table 133. Asia Cyazofamid Revenue by Type (2021-2026) & (US$ Million) Table 134. Asia Cyazofamid Revenue by Type (2027-2032) & (US$ Million) Table 135. Asia Cyazofamid Sales by Type (2021-2026) & (kt) Table 136. Asia Cyazofamid Sales by Type (2027-2032) & (kt) Table 137. Asia Cyazofamid Sales Price by Type (2021-2026) & (USD/t) Table 138. Asia Cyazofamid Sales Price by Type (2027-2032) & (USD/t) Table 139. Asia Cyazofamid Revenue by Application (2021-2026) & (US$ Million) Table 140. Asia Cyazofamid Revenue by Application (2027-2032) & (US$ Million) Table 141. Asia Cyazofamid Sales by Application (2021-2026) & (kt) Table 142. Asia Cyazofamid Sales by Application (2027-2032) & (kt) Table 143. Asia Cyazofamid Sales Price by Application (2021-2026) & (USD/t) Table 144. Asia Cyazofamid Sales Price by Application (2027-2032) & (USD/t) Table 145. Asia Cyazofamid Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 146. Asia Cyazofamid Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 147. Asia Cyazofamid Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 148. Asia Cyazofamid Sales by Country (2021 VS 2025 VS 2032) & (kt) Table 149. Asia Cyazofamid Sales by Country (2021-2026) & (kt) Table 150. Asia Cyazofamid Sales by Country (2027-2032) & (kt) Table 151. Asia Cyazofamid Sales Price by Country (2021-2026) & (USD/t) Table 152. Asia Cyazofamid Sales Price by Country (2027-2032) & (USD/t) Table 153. Japan Cyazofamid Revenue (2021-2032) & (US$ Million) Table 154. South Korea Cyazofamid Revenue (2021-2032) & (US$ Million) Table 155. India Cyazofamid Revenue (2021-2032) & (US$ Million) Table 156. Australia Cyazofamid Revenue (2021-2032) & (US$ Million) Table 157. Taiwan Cyazofamid Revenue (2021-2032) & (US$ Million) Table 158. Southeast Asia Cyazofamid Revenue (2021-2032) & (US$ Million) Table 159. SAMEA Cyazofamid Revenue by Type (2021-2026) & (US$ Million) Table 160. SAMEA Cyazofamid Revenue by Type (2027-2032) & (US$ Million) Table 161. SAMEA Cyazofamid Sales by Type (2021-2026) & (kt) Table 162. SAMEA Cyazofamid Sales by Type (2027-2032) & (kt) Table 163. SAMEA Cyazofamid Sales Price by Type (2021-2026) & (USD/t) Table 164. SAMEA Cyazofamid Sales Price by Type (2027-2032) & (USD/t) Table 165. SAMEA Cyazofamid Revenue by Application (2021-2026) & (US$ Million) Table 166. SAMEA Cyazofamid Revenue by Application (2027-2032) & (US$ Million) Table 167. SAMEA Cyazofamid Sales by Application (2021-2026) & (kt) Table 168. SAMEA Cyazofamid Sales by Application (2027-2032) & (kt) Table 169. SAMEA Cyazofamid Sales Price by Application (2021-2026) & (USD/t) Table 170. SAMEA Cyazofamid Sales Price by Application (2027-2032) & (USD/t) Table 171. SAMEA Cyazofamid Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 172. SAMEA Cyazofamid Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 173. SAMEA Cyazofamid Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 174. SAMEA Cyazofamid Sales by Country (2021 VS 2025 VS 2032) & (kt) Table 175. SAMEA Cyazofamid Sales by Country (2021-2026) & (kt) Table 176. SAMEA Cyazofamid Sales by Country (2027-2032) & (kt) Table 177. SAMEA Cyazofamid Sales Price by Country (2021-2026) & (USD/t) Table 178. SAMEA Cyazofamid Sales Price by Country (2027-2032) & (USD/t) Table 179. Brazil Cyazofamid Revenue (2021-2032) & (US$ Million) Table 180. Argentina Cyazofamid Revenue (2021-2032) & (US$ Million) Table 181. Chile Cyazofamid Revenue (2021-2032) & (US$ Million) Table 182. Colombia Cyazofamid Revenue (2021-2032) & (US$ Million) Table 183. Peru Cyazofamid Revenue (2021-2032) & (US$ Million) Table 184. Saudi Arabia Cyazofamid Revenue (2021-2032) & (US$ Million) Table 185. Israel Cyazofamid Revenue (2021-2032) & (US$ Million) Table 186. UAE Cyazofamid Revenue (2021-2032) & (US$ Million) Table 187. Turkey Cyazofamid Revenue (2021-2032) & (US$ Million) Table 188. Iran Cyazofamid Revenue (2021-2032) & (US$ Million) Table 189. Egypt Cyazofamid Revenue (2021-2032) & (US$ Million) Table 190. Key Raw Materials Table 191. Raw Materials Key Suppliers Table 192. Cyazofamid Distributors List Table 193. Cyazofamid Customers List Table 194. Research Programs/Design for This Report Table 195. Authors List of This Report Table 196. Secondary Sources Table 197. Primary Sources List of Figures Figure 1. Cyazofamid Product Image Figure 2. Global Cyazofamid Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Cyazofamid Market Size Share 2021 VS 2025 VS 2032 Figure . Agriculture Grade Image Figure 1. Others Image Figure 2. Global Cyazofamid Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Cyazofamid Market Size Share 2021 VS 2025 VS 2032 Figure 4. Downy Mildew Image Figure 5. Oomycetes Diseases Image Figure 6. Others Image Figure 7. Global Cyazofamid Capacity, Capacity Utilization (2021-2032) & (kt) Figure 8. Global Cyazofamid Production by Region: 2021 VS 2025 VS 2032 (kt) Figure 9. Global Cyazofamid Production Market Share by Region: 2025 Versus 2032 Figure 10. Global Cyazofamid Production Market Share by Region (2021-2032) Figure 11. North America Cyazofamid Production Growth Rate (2021-2032) & (kt) Figure 12. Europe Cyazofamid Production Growth Rate (2021-2032) & (kt) Figure 13. China Cyazofamid Production Growth Rate (2021-2032) & (kt) Figure 14. Japan Cyazofamid Production Growth Rate (2021-2032) & (kt) Figure 15. Global Cyazofamid Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 16. Global Cyazofamid Revenue (2021-2032) & (US$ Million) Figure 17. Global Cyazofamid Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 18. Global Cyazofamid Revenue Market Share by Region: 2025 Versus 2032 Figure 19. Global Cyazofamid Revenue Market Share by Region (2021-2032) Figure 20. Global Cyazofamid Sales (2021-2032) & (kt) Figure 21. Global Cyazofamid Sales by Region: 2021 VS 2025 VS 2032 (kt) Figure 22. Global Cyazofamid Sales Market Share by Region (2021-2032) Figure 23. North America Cyazofamid Sales YoY (2021-2032) & (kt) Figure 24. Europe Cyazofamid Sales YoY (2021-2032) & (kt) Figure 25. China Cyazofamid Sales YoY (2021-2032) & (kt) Figure 26. Asia (Excluding China) Cyazofamid Sales YoY (2021-2032) & (kt) Figure 27. South America, Middle East and Africa Cyazofamid Sales YoY (2021-2032) & (kt) Figure 28. Global Cyazofamid Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 29. Global Cyazofamid Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 30. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 31. Global Cyazofamid Revenue Market Share by Type (2021-2032) Figure 32. Global Cyazofamid Sales Market Share by Type (2021-2032) Figure 33. Global Cyazofamid Revenue Market Share by Application (2021-2032) Figure 34. Global Cyazofamid Sales Market Share by Application (2021-2032) Figure 35. North America Cyazofamid Revenue Share by Type (2021-2032) Figure 36. North America Cyazofamid Sales Share by Type (2021-2032) Figure 37. North America Cyazofamid Revenue Share by Application (2021-2032) Figure 38. North America Cyazofamid Sales Share by Application (2021-2032) Figure 39. North America Cyazofamid Revenue Share by Country (2021-2032) Figure 40. North America Cyazofamid Sales Share by Country (2021-2032) Figure 41. Europe Cyazofamid Revenue Share by Type (2021-2032) Figure 42. Europe Cyazofamid Sales Share by Type (2021-2032) Figure 43. Europe Cyazofamid Revenue Share by Application (2021-2032) Figure 44. Europe Cyazofamid Sales Share by Application (2021-2032) Figure 45. Europe Cyazofamid Revenue Share by Country (2021-2032) Figure 46. Europe Cyazofamid Sales Share by Country (2021-2032) Figure 47. China Cyazofamid Revenue Share by Type (2021-2032) Figure 48. China Cyazofamid Sales Share by Type (2021-2032) Figure 49. China Cyazofamid Revenue Share by Application (2021-2032) Figure 50. China Cyazofamid Sales Share by Application (2021-2032) Figure 51. Asia Cyazofamid Revenue Share by Type (2021-2032) Figure 52. Asia Cyazofamid Sales Share by Type (2021-2032) Figure 53. Asia Cyazofamid Revenue Share by Application (2021-2032) Figure 54. Asia Cyazofamid Sales Share by Application (2021-2032) Figure 55. Asia Cyazofamid Revenue Share by Country (2021-2032) Figure 56. Asia Cyazofamid Sales Share by Country (2021-2032) Figure 57. SAMEA Cyazofamid Revenue Share by Type (2021-2032) Figure 58. SAMEA Cyazofamid Sales Share by Type (2021-2032) Figure 59. SAMEA Cyazofamid Revenue Share by Application (2021-2032) Figure 60. SAMEA Cyazofamid Sales Share by Application (2021-2032) Figure 61. SAMEA Cyazofamid Revenue Share by Country (2021-2032) Figure 62. SAMEA Cyazofamid Sales Share by Country (2021-2032) Figure 63. Cyazofamid Value Chain Figure 64. Manufacturing Cost Structure Figure 65. Cyazofamid Production Mode & Process Figure 66. Direct Comparison with Distribution Share Figure 67. Distributors Profiles Figure 68. Years Considered Figure 69. Research Process Figure 70. Key Executives Interviewed

Scope & coverage.

Types
  • Agriculture Grade
  • Others
Applications
  • Downy Mildew
  • Oomycetes Diseases
  • Others
Companies covered
  • ISHIHARA SANGYO KAISHA
  • Rudong Zhongyi

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Cyazofamid Market by Type
  3. 1.2.1 Global Cyazofamid Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Agriculture Grade
  5. 1.2.3 Others
  6. 1.3 Cyazofamid Market by Application
  7. 1.3.1 Global Cyazofamid Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Downy Mildew
  9. 1.3.3 Oomycetes Diseases
  10. 1.3.4 Others
  11. 1.4 Assumptions and Limitations
  12. 1.5 Study Goals and Objectives
2 Cyazofamid Market Dynamics
  1. 2.1 Cyazofamid Industry Trends
  2. 2.2 Cyazofamid Industry Drivers
  3. 2.3 Cyazofamid Industry Opportunities and Challenges
  4. 2.4 Cyazofamid Industry Restraints
3 Global Cyazofamid Production Overview
  1. 3.1 Global Cyazofamid Production Capacity (2021-2032)
  2. 3.2 Global Cyazofamid Production by Region: 2021 VS 2025 VS 2032
  3. 3.3 Global Cyazofamid Production by Region
  4. 3.3.1 Global Cyazofamid Production by Region (2021-2026)
  5. 3.3.2 Global Cyazofamid Production by Region (2027-2032)
  6. 3.3.3 Global Cyazofamid Production Market Share by Region (2021-2032)
  7. 3.4 North America
  8. 3.5 Europe
  9. 3.6 China
  10. 3.7 Japan
4 Global Market Growth Prospects
  1. 4.1 Global Cyazofamid Revenue Estimates and Forecasts (2021-2032)
  2. 4.2 Global Cyazofamid Revenue by Region
  3. 4.2.1 Global Cyazofamid Revenue by Region: 2021 VS 2025 VS 2032
  4. 4.2.2 Global Cyazofamid Revenue by Region (2021-2026)
  5. 4.2.3 Global Cyazofamid Revenue by Region (2027-2032)
  6. 4.2.4 Global Cyazofamid Revenue Market Share by Region (2021-2032)
  7. 4.3 Global Cyazofamid Sales Estimates and Forecasts 2021-2032
  8. 4.4 Global Cyazofamid Sales by Region
  9. 4.4.1 Global Cyazofamid Sales by Region: 2021 VS 2025 VS 2032
  10. 4.4.2 Global Cyazofamid Sales by Region (2021-2026)
  11. 4.4.3 Global Cyazofamid Sales by Region (2027-2032)
  12. 4.4.4 Global Cyazofamid Sales Market Share by Region (2021-2032)
  13. 4.5 North America
  14. 4.6 Europe
  15. 4.7 China
  16. 4.8 Asia (Excluding China)
  17. 4.9 South America, Middle East and Africa
5 Market Competitive Landscape by Manufacturers
  1. 5.1 Global Cyazofamid Revenue by Manufacturers
  2. 5.1.1 Global Cyazofamid Revenue by Manufacturers (2021-2026)
  3. 5.1.2 Global Cyazofamid Revenue Market Share by Manufacturers (2021-2026)
  4. 5.1.3 Global Cyazofamid Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 5.2 Global Cyazofamid Sales by Manufacturers
  6. 5.2.1 Global Cyazofamid Sales by Manufacturers (2021-2026)
  7. 5.2.2 Global Cyazofamid Sales Market Share by Manufacturers (2021-2026)
  8. 5.2.3 Global Cyazofamid Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 5.3 Global Cyazofamid Sales Price by Manufacturers (2021-2026)
  10. 5.4 Global Cyazofamid Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 5.5 Global Cyazofamid Key Manufacturers Manufacturing Sites & Headquarters
  12. 5.6 Global Cyazofamid Manufacturers, Product Type & Application
  13. 5.7 Global Cyazofamid Manufacturers Commercialization Time
  14. 5.8 Market Competitive Analysis
  15. 5.8.1 Global Cyazofamid Market CR5 and HHI
  16. 5.8.2 2025 Cyazofamid Tier 1, Tier 2, and Tier 3
6 Cyazofamid Market by Type
  1. 6.1 Global Cyazofamid Revenue by Type
  2. 6.1.1 Global Cyazofamid Revenue by Type (2021-2032) & (US$ Million)
  3. 6.1.2 Global Cyazofamid Revenue Market Share by Type (2021-2032)
  4. 6.2 Global Cyazofamid Sales by Type
  5. 6.2.1 Global Cyazofamid Sales by Type (2021-2032) & (kt)
  6. 6.2.2 Global Cyazofamid Sales Market Share by Type (2021-2032)
  7. 6.3 Global Cyazofamid Price by Type
7 Cyazofamid Market by Application
  1. 7.1 Global Cyazofamid Revenue by Application
  2. 7.1.1 Global Cyazofamid Revenue by Application (2021-2032) & (US$ Million)
  3. 7.1.2 Global Cyazofamid Revenue Market Share by Application (2021-2032)
  4. 7.2 Global Cyazofamid Sales by Application
  5. 7.2.1 Global Cyazofamid Sales by Application (2021-2032) & (kt)
  6. 7.2.2 Global Cyazofamid Sales Market Share by Application (2021-2032)
  7. 7.3 Global Cyazofamid Price by Application
8 Company Profiles
  1. 8.1 ISHIHARA SANGYO KAISHA
  2. 8.1.1 ISHIHARA SANGYO KAISHA Company Information
  3. 8.1.2 ISHIHARA SANGYO KAISHA Business Overview
  4. 8.1.3 ISHIHARA SANGYO KAISHA Cyazofamid Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 8.1.4 ISHIHARA SANGYO KAISHA Cyazofamid Product Portfolio
  6. 8.1.5 ISHIHARA SANGYO KAISHA Recent Developments
  7. 8.2 Rudong Zhongyi
  8. 8.2.1 Rudong Zhongyi Company Information
  9. 8.2.2 Rudong Zhongyi Business Overview
  10. 8.2.3 Rudong Zhongyi Cyazofamid Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 8.2.4 Rudong Zhongyi Cyazofamid Product Portfolio
  12. 8.2.5 Rudong Zhongyi Recent Developments
9 North America
  1. 9.1 North America Cyazofamid Market Size by Type
  2. 9.1.1 North America Cyazofamid Revenue by Type (2021-2032)
  3. 9.1.2 North America Cyazofamid Sales by Type (2021-2032)
  4. 9.1.3 North America Cyazofamid Price by Type (2021-2032)
  5. 9.2 North America Cyazofamid Market Size by Application
  6. 9.2.1 North America Cyazofamid Revenue by Application (2021-2032)
  7. 9.2.2 North America Cyazofamid Sales by Application (2021-2032)
  8. 9.2.3 North America Cyazofamid Price by Application (2021-2032)
  9. 9.3 North America Cyazofamid Market Size by Country
  10. 9.3.1 North America Cyazofamid Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 North America Cyazofamid Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 North America Cyazofamid Price by Country (2021-2032)
  13. 9.3.4 United States
  14. 9.3.5 Canada
  15. 9.3.6 Mexico
10 Europe
  1. 10.1 Europe Cyazofamid Market Size by Type
  2. 10.1.1 Europe Cyazofamid Revenue by Type (2021-2032)
  3. 10.1.2 Europe Cyazofamid Sales by Type (2021-2032)
  4. 10.1.3 Europe Cyazofamid Price by Type (2021-2032)
  5. 10.2 Europe Cyazofamid Market Size by Application
  6. 10.2.1 Europe Cyazofamid Revenue by Application (2021-2032)
  7. 10.2.2 Europe Cyazofamid Sales by Application (2021-2032)
  8. 10.2.3 Europe Cyazofamid Price by Application (2021-2032)
  9. 10.3 Europe Cyazofamid Market Size by Country
  10. 10.3.1 Europe Cyazofamid Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 10.3.2 Europe Cyazofamid Sales by Country (2021 VS 2025 VS 2032)
  12. 10.3.3 Europe Cyazofamid Price by Country (2021-2032)
  13. 10.3.4 Germany
  14. 10.3.5 France
  15. 10.3.6 U.K.
  16. 10.3.7 Italy
  17. 10.3.8 Russia
  18. 10.3.9 Spain
  19. 10.3.10 Netherlands
  20. 10.3.11 Switzerland
  21. 10.3.12 Sweden
11 China
  1. 11.1 China Cyazofamid Market Size by Type
  2. 11.1.1 China Cyazofamid Revenue by Type (2021-2032)
  3. 11.1.2 China Cyazofamid Sales by Type (2021-2032)
  4. 11.1.3 China Cyazofamid Price by Type (2021-2032)
  5. 11.2 China Cyazofamid Market Size by Application
  6. 11.2.1 China Cyazofamid Revenue by Application (2021-2032)
  7. 11.2.2 China Cyazofamid Sales by Application (2021-2032)
  8. 11.2.3 China Cyazofamid Price by Application (2021-2032)
12 Asia (Excluding China)
  1. 12.1 Asia Cyazofamid Market Size by Type
  2. 12.1.1 Asia Cyazofamid Revenue by Type (2021-2032)
  3. 12.1.2 Asia Cyazofamid Sales by Type (2021-2032)
  4. 12.1.3 Asia Cyazofamid Price by Type (2021-2032)
  5. 12.2 Asia Cyazofamid Market Size by Application
  6. 12.2.1 Asia Cyazofamid Revenue by Application (2021-2032)
  7. 12.2.2 Asia Cyazofamid Sales by Application (2021-2032)
  8. 12.2.3 Asia Cyazofamid Price by Application (2021-2032)
  9. 12.3 Asia Cyazofamid Market Size by Country
  10. 12.3.1 Asia Cyazofamid Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 Asia Cyazofamid Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 Asia Cyazofamid Price by Country (2021-2032)
  13. 12.3.4 Japan
  14. 12.3.5 South Korea
  15. 12.3.6 India
  16. 12.3.7 Australia
  17. 12.3.8 Taiwan
  18. 12.3.9 Southeast Asia
13 South America, Middle East and Africa
  1. 13.1 SAMEA Cyazofamid Market Size by Type
  2. 13.1.1 SAMEA Cyazofamid Revenue by Type (2021-2032)
  3. 13.1.2 SAMEA Cyazofamid Sales by Type (2021-2032)
  4. 13.1.3 SAMEA Cyazofamid Price by Type (2021-2032)
  5. 13.2 SAMEA Cyazofamid Market Size by Application
  6. 13.2.1 SAMEA Cyazofamid Revenue by Application (2021-2032)
  7. 13.2.2 SAMEA Cyazofamid Sales by Application (2021-2032)
  8. 13.2.3 SAMEA Cyazofamid Price by Application (2021-2032)
  9. 13.3 SAMEA Cyazofamid Market Size by Country
  10. 13.3.1 SAMEA Cyazofamid Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 13.3.2 SAMEA Cyazofamid Sales by Country (2021 VS 2025 VS 2032)
  12. 13.3.3 SAMEA Cyazofamid Price by Country (2021-2032)
  13. 13.3.4 Brazil
  14. 13.3.5 Argentina
  15. 13.3.6 Chile
  16. 13.3.7 Colombia
  17. 13.3.8 Peru
  18. 13.3.9 Saudi Arabia
  19. 13.3.10 Israel
  20. 13.3.11 UAE
  21. 13.3.12 Turkey
  22. 13.3.13 Iran
  23. 13.3.14 Egypt
14 Value Chain and Sales Channels Analysis
  1. 14.1 Cyazofamid Value Chain Analysis
  2. 14.1.1 Cyazofamid Key Raw Materials
  3. 14.1.2 Raw Materials Key Suppliers
  4. 14.1.3 Manufacturing Cost Structure
  5. 14.1.4 Cyazofamid Production Mode & Process
  6. 14.2 Cyazofamid Sales Channels Analysis
  7. 14.2.1 Direct Comparison with Distribution Share
  8. 14.2.2 Cyazofamid Distributors
  9. 14.2.3 Cyazofamid Customers
15 Concluding Insights
    16 Appendix
    1. 16.1 Reasons for Doing This Study
    2. 16.2 Research Methodology
    3. 16.3 Research Process
    4. 16.4 Authors List of This Report
    5. 16.5 Data Source
    6. 16.5.1 Secondary Sources
    7. 16.5.2 Primary Sources
    8. 16.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst